BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ASXL1, ENSG00000171456, 171023, Q8IXJ9, MGC71111, MGC117280, KIAA0978
8 results:

  • 1. New insights on familial colorectal cancer type X syndrome.
    Garcia FAO; de Andrade ES; de Campos Reis Galvão H; da Silva Sábato C; Campacci N; de Paula AE; Evangelista AF; Santana IVV; Melendez ME; Reis RM; Palmero EI
    Sci Rep; 2022 Feb; 12(1):2846. PubMed ID: 35181726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cell Models for Chromosome 20q11.21 Amplification and Drug Sensitivities in colorectal cancer.
    Voutsadakis IA
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577783
    [No Abstract]    [Full Text] [Related]  

  • 3. Loss of asxl1 expression is associated with lymph node metastasis in colorectal cancer.
    Lee JH; Lee JH; Ahn BK; Paik SS; Kim H; Lee KH
    Indian J Pathol Microbiol; 2020; 63(2):221-225. PubMed ID: 32317519
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive Analysis of Somatic Mutations in colorectal cancer With Peritoneal Metastasis.
    Lee JH; Ahn BK; Baik SS; Lee KH
    In Vivo; 2019; 33(2):447-452. PubMed ID: 30804124
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.
    Slattery ML; Herrick JS; Mullany LE; Samowitz WS; Sevens JR; Sakoda L; Wolff RK
    Genes Chromosomes Cancer; 2017 Nov; 56(11):769-787. PubMed ID: 28675510
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Functional proteomics of the epigenetic regulators asxl1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
    Katoh M
    Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Functional and cancer genomics of ASXL family members.
    Katoh M
    Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability.
    Williams DS; Bird MJ; Jorissen RN; Yu YL; Walker F; Zhang HH; Nice EC; Burgess AW
    PLoS One; 2010 Dec; 5(12):e16012. PubMed ID: 21209843
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.